Exact Mass: 571.1275656
Exact Mass Matches: 571.1275656
Found 33 metabolites which its exact mass value is equals to given mass value 571.1275656,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cyclochlorotine
Islanditoxin
Islanditoxin is a mycotoxin produced by the common food storage mould Penicillium islandicu
Cyclochlorotine
Cyclochlorotine is a mycotoxin produced by the common food storage mould Penicillium islandicu
4-O-alpha-L-Rhamnopyranosylglucosinalbin
4-O-alpha-L-Rhamnopyranosylglucosinalbin is found in fats and oils. 4-O-alpha-L-Rhamnopyranosylglucosinalbin is a constituent of Moringa oleifera (horseradish tree) and Moringa peregrina Constituent of Moringa oleifera (horseradish tree) and Moringa peregrina. Glucosinalbin 4-rhamnoside is found in fats and oils, herbs and spices, and green vegetables.
Baloxavir marboxil
Telaglenastat
C471 - Enzyme Inhibitor Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity[1].
2-(alpha-L-Arabinopyranosyloxyl)-2-phenylethyl glucosinolate
2-(alpha-L-Rhamnopyranosyloxy)benzyl glucosinolate
Islanditoxin
4-O-a-L-Rhamnopyranosylglucosinalbin
Benzamide, N-[1-[(2R)-3,5-di-O-benzoyl-2-deoxy-2-fluoro-2-methyl-α-D-erythro-pentofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]
baloxavir marboxil
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors
(2R)-N-Benzoyl-2-deoxy-2-fluoro-2-methylcytidine 3,5-dibenzoate
Telaglenastat
C471 - Enzyme Inhibitor Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity[1].
dTDP-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitroso-beta-L-arabino-hexopyranose
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
(3S,7R,9S,13S,16R)-17,18-dichloro-13-ethyl-3,9-bis(hydroxymethyl)-7-phenyl-1,4,8,11,14-pentazabicyclo[14.3.0]nonadecane-2,5,10,12,15-pentone
17,18-Dichloro-9-ethyl-3,6-bis(hydroxymethyl)-13-phenyl-1,4,7,10,14-pentazabicyclo[14.3.0]nonadecane-2,5,8,11,15-pentone
CMP-3-deoxy-D-glycero-beta-D-galacto-nonulosonate(2-)
A nucleotide-sugar oxoanion obtained by deprotonation of the carboxylic acid and phosphate functions of CMP-3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid; major species at pH 7.3.
